These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32750219)

  • 1. Off-label prescribing of targeted anticancer therapy at a large pediatric cancer center.
    Lim M; Shulman DS; Roberts H; Li A; Clymer J; Bona K; Al-Sayegh H; Ma C; DuBois SG
    Cancer Med; 2020 Sep; 9(18):6658-6666. PubMed ID: 32750219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-Label Prescribing for Children with Migraines in U.S. Ambulatory Care Settings.
    Lai LL; Koh L; Ho JA; Ting A; Obi A
    J Manag Care Spec Pharm; 2017 Mar; 23(3):382-387. PubMed ID: 28230456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-label and off-label prescribing patterns of erythropoiesis-stimulating agents in inpatient hospital settings in the US during the period of major regulatory changes.
    Seetasith A; Holdford D; Shah A; Patterson J
    Res Social Adm Pharm; 2017; 13(4):778-788. PubMed ID: 27595426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and predictors of off-label prescription of psychiatric drugs.
    Vijay A; Becker JE; Ross JS
    PLoS One; 2018; 13(7):e0198363. PubMed ID: 30024873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label prescribing to children in the United States outpatient setting.
    Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
    Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
    Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
    Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label prescribing patterns of antidepressants in children and adolescents.
    Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data.
    Akıcı N; Kırmızı Nİ; Aydın V; Bayar B; Aksoy M; Akıcı A
    Turk J Pediatr; 2020; 62(6):949-961. PubMed ID: 33372433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children.
    Schaffer AL; Bruno C; Buckley NA; Cairns R; Litchfield M; Paget S; Zoega H; Nassar N; Pearson SA
    Paediatr Perinat Epidemiol; 2022 Sep; 36(5):726-737. PubMed ID: 35172017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.
    Oshikoya KA; Wharton GT; Avant D; Van Driest SL; Fenn NE; Lardieri A; Doe E; Sood BG; Taketomo C; Lieu P; Yen L; McMahon AW
    Paediatr Drugs; 2019 Feb; 21(1):47-58. PubMed ID: 30484072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label Medication Prescribing Patterns in Pediatrics: An Update.
    Yackey K; Stukus K; Cohen D; Kline D; Zhao S; Stanley R
    Hosp Pediatr; 2019 Mar; 9(3):186-193. PubMed ID: 30745323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center.
    Cenna R; Basiricò M; Berchialla P; Bertorello N; Cagnazzo C; Ceolin V; De Luna E; Nolis C; Resente F; Fagioli F
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30148. PubMed ID: 36583462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing of zoledronic acid in a tertiary outpatient hospital setting.
    Anglada-Martínez H; do Pazo-Oubiña F; Molas-Ferrer G; Estefanell-Tejero A; Riu-Viladoms G; Ribas-Sala J; Creus-Baró N
    Int J Clin Pharm; 2012 Dec; 34(6):832-6. PubMed ID: 22956210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
    Kocs D; Fendrick AM
    Am J Manag Care; 2003 May; 9(5):393-400; quiz 401-2. PubMed ID: 12744301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world assessment of off-label direct oral anticoagulant dosing for venous thromboembolism.
    Saunders JA; Gustafson WL; Vazquez SR; Jones AE; Witt DM
    J Thromb Thrombolysis; 2019 Oct; 48(3):506-510. PubMed ID: 31230262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.
    Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label antidepressant prescription in pediatric outpatients based on China Food and Drug Administration and Food and Drug Administration regulations: a Chinese retrospective study.
    Deng S; Zhu X; Sun B; Hu J; Shang D; Chen W; Lu H; Ni X; Zhang M; Wang Z; Wen Y; Qiu C
    Int Clin Psychopharmacol; 2018 May; 33(3):172-179. PubMed ID: 29505485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label prescribing in pediatric outpatients.
    Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
    Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.